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1684-1182/Copyright ª 2014, Taiwan S
BY-NC-ND license (http://creativecomBackground: The EHF and ELF5 genes, located on chromosome 11p and linked to asthma phe-
notypes, are high-potential candidate genes conferring asthma susceptibility. The purpose of
this study was to investigate the genetic association among single nucleotide polymorphisms
(SNPs) of EHF and ELF5, and their relationship with asthma in the Taiwanese population.
Methods: We selected and performed genotyping on 16 SNPs that encompass the genomic re-
gion of EHF and ELF5 in Taiwanese children with or without asthma. A total of 1983 children,
523 in the test group and 619 and 842 in two validation groups, were recruited for this study.
Results: The SNP rs3910901, located in the 50 upstream region of ELF5, was found to have a
weak association (pZ 0.043) with asthma in the odds ratio analysis. The genotype distribution
was similar in all comparison groups, but the CC genotype was more frequent in asthma pa-
tients. Logistic regression adjusted allergy comorbidity showed obviously diluted association.
Conclusion: The results indicated that SNP rs3910901 may have a minor impact on pediatric
asthma in the Taiwanese population.
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Chronic asthma is a complex disease that affects approxi-
mately 300 million individuals worldwide.1 The rising inci-
dence of asthma and atopic disorders over recent decades
attests to the importance of environmental and lifestyle
factors in risk assessment.2e4 Strong genetic components
associated with asthma were supported by family and twin
studies.5,6 Many genes have been identified or are sus-
pected of being involved the pathogenesis of asthma.7 In
Taiwan, there are some slight differences in the reported
symptoms of allergic diseases; nevertheless, the preva-
lence of allergic diseases is rising.8e10
E74-like factor 5 (ELF5; also known as ESE-2) and ETS
homologous factor (EHF; also known as ESE-3) are members
of the epithelium-specific ETS transcription factor sub-
family.11e14 ELF5 and EHF are thought to involve the induc-
tion or repression of epithelium-specific genes in the context
of an inflammatory microenvironment and oncogenes of
epithelium-derived tumors in tubulogenesis, as well as a
branch of morphogenesis glandular organs, such as the
lung.11e14 EHF and another member of the ETS family tran-
scription factors, ESE-1, are upregulated by the inflamma-
tory cytokines interleukin-1 and tumor necrosis factor-a in
bronchial epithelial cell lines. The results indicated that EHF
should play an important role in airway inflammation.15
ELF5 and EHF, located on chromosome 11p12e15, were
identified as candidate genes for asthma in a genome-wide
linkage analysis performed in a population from Tristan de
Cunha.16e18 The ELF5 polymorphism was found to be asso-
ciated with a weak effect on adults (aged 18e45 years) with
asthma in the Caucasian population.19 Our previous study
found that the microsatellite marker in chromosome 11p13,
near ELF5 and EHF, was associated with the immunoglob-
ulin E (IgE) level in asthmatic children.20 The limitations of
the previous genetic study on the relation of EHF and ELF5
with asthma were the restriction of sample size, fewer
single nucleotide polymorphism (SNP) targets, and lack of
adjustment by allergy comorbidity.
In the present study, we investigated the association
between selected SNPs of the EHF-ELF5 genomic region and
asthma. The results were validated in independently
recruited participants.
Materials and Methods
Sample composition and clinical evaluation
Our study population consisted of asthmatic children aged
5e12 years. The study protocol was approved by the Ethical
and Clinical Trial Committee of National Cheng-Kung Uni-
versity Hospital and Mackay Memorial Hospital, Taiwan. An
informed consent form was required for all participants or
their guardians after answering a modified British Medical
Society respiratory questionnaire, which is identical to the
European Community Respiratory Health Survey (ERCHS).
These surveys showed similar results as those of Interna-
tional Study of Asthma and Allergies in Childhood (ISAAC) and
ERCHS, pertinent to the diagnosis and assessment of
asthma.21,22 Pulmonary function was evaluated using stan-
dard methods including spirometry before and after theadministration of two puffs of inhaled salbutamol (200 mg/
puff). The definition of asthma must meet the following
criteria: (1) a history ofwheezing and experiencing shortness
of breath during or without concurrent respiratory in-
fections; (2) chronic coughing for >1 month, as well as the
presence of wheezing, as observed by a physician; and (3) a
bronchodilator test confirms a 15% increase in FEV1 (forced
expiratory volume in 1 second). Nonasthma controls were
defined as neither having asthma history as in criterion (1)
above nor being diagnosed as in criterion (2). Other evalua-
tions included skin prick tests for responsiveness to six
common aeroallergens, a differential blood count (including
total eosinophil count), levels of total serum IgE, as well as
IgE specific to house dust andmixed pollens using the Unicap
system (PharmaciaDiagnostics, Uppsala, Sweden). A positive
skin test was defined as the presence of  1 reaction with a
wheal diameter 5mm. Total serum IgEwasmeasured using
solid-phase immunoassay (Pharmacia IgE EIA; Pharmacia
Diagnostics). Nonallergy patients were defined as having a
total serum IgE < 200 IU/mL and a negative skin test. All
participants were Han Taiwanese and living in Taiwan.
DNA preparation
Genomic DNA was extracted from the blood samples of the
study participants using a QIAamp DNA Blood kit (Qiagen,
Valencia, CA, USA). The extracted genomic DNA was
analyzed by agarose gel electrophoresis, quantified by
spectrophotometer, and stored at 80C until use.
SNP selection and genotyping
The EHF-ELF5 genomic region encompasses two genes
spanning 183.5 kb. We selected 16 SNPs within and near the
EHF and ELF5 genes to determine the genotyping association
results. All SNP genotyping tests were performed using the
Taqman SNP genotyping assays (Applied Biosystems, Foster
City, CA, USA). The primers and probes of the selected SNPs
were from the Applied Biosystems Assay on Demand kit. The
probe fluorescence signal was detected using the ABI Prism
7900 Real-Time PCR System (Applied Biosystems).
Statistical analysis
The quality of the genotype data was evaluated using Har-
dyeWeinbergequilibrium(HWE)proportion tests. Intermarker
linkage disequilibrium measures, r2 and D0, were estimated
and haplotype blocks were defined using the Haploview pro-
gram.23 All of the single-point association analyses were car-
ried out using the SAS/genetics package (SAS, Cary, NC, USA).
SNPs showed significant association (p 0.05) in the tests. The
odds ratio (OR) was evaluated using logistic regression to
demonstrate which genotype was adjusted to allergy.
Results
Characteristics of the study participants
Five hundred and twenty-three DNA samples extracted
from 239 nonasthmatic children and 284 asthmatic children
EHF-ELF5 and asthma 881were collected as Group 1 and genotyping was performed
on all selected SNPs. There were 619 participants (including
258 asthmatic children and 361 controls) in Group 2 that
were recruited from the same hospital as Group 1 at a
different time. Group 3 included 670 asthmatic children
and 172 controls that were recruited from two different
hospitals. There were significant differences in the distri-
bution of sex and allergy comorbidity between participants
with and without asthma in the three groups (Table 1).rs3910901 SNP in the genomic region between EHF
and ELF5 associated with asthma
Sixteen SNPs randomly selected from the EHF and ELF5
genomic region were genotyped for every participant. The
genotype distributions of the SNPs did not deviate from the
HWE in either asthmatic or nonasthmatic participants.
Linkage disequilibrium values of the polymorphic SNPs in
the EHF and ELF5 genes are listed in Fig. 1. Two and one
haplo-blocks were identified in the ELF5 and EHF genes,
respectively.
The strengths of associations and genotype frequencies
of all selected SNPs with asthma are summarized in Table 2.
None of the SNPs appeared to be significantly associated
with asthma. The rs3901901SNP located upstream of the
ELF5 gene showed weak significance in the OR analysis
(p Z 0.043). There was not a single SNP displaying a sta-
tistically significant difference after Bonferroni correction.
Determination and validation of the results were
described above; genotyping of the associated SNPs for
Group 2 and Group 3 was performed. The genotype distri-
butions of rs3901901 in Group 2 and Group 3 did not deviate
from the HWE either in asthmatic or nonasthmatic partici-
pants. The rs3901901 SNP displayed marginal significance in
both groups (genotypic and OR analysis), and was statisti-
cally significant when the total number of participants was
considered (Table 3). The OR analysis showed that the CC
genotype of the rs3901901SNP was associated with the risk
of asthma, and this association was consistent among the
three groups and the total number of participants (Table 3).Table 1 Sex and allergy information of the study participants
Group 1
Case a Control b Cas
Sex
Male 196 105 167
Female 88 134 91
p value <0.0001 0.00
OR (95% CI) 2.84 (1.99e4.07) 1.93
Allergy
Yes 203 80 215
No 81 159 43
p value <0.0001 <0.
OR (95% CI) 4.98 (3.43, 7.23) 4.65
a Asthma patients.
b Nonasthma participants.
Allergy defined as total IgE > 250 IU/mL and positive skin test to six
CI Z confidence interval; OR Z odds ratio.Although the results were not significant or strongly asso-
ciated with asthma, the trend in the genotype distribution
was similar across all comparison groups. Genotype CC was
found more frequently in asthma patients in all comparison
groups. The effects of rs3901901 on asthma were further
adjusted to the influence of sex and allergy comorbidity by
logistic regression. As shown in Table 3, the strength of
associations was not observed to be diluted by sex, but was
obviously affected by allergy comorbidity.
The OR analysis of rs3901901 and allergy were also
performed for the total number of participants. The CC
genotype appeared to be significantly associated with the
risk of allergy with an OR of 1.72, 95% confidence interval of
1.06e2.80, and a p value Z 0.026. The significance was
dramatically diluted by adjustment with asthma
(p Z 0.347) using logistic regression.Discussion
In the current study, we investigated the association be-
tween the EHF and ELF5 polymorphisms and pediatric
asthma. We found that association between the asthma
phenotype and ELF5 polymorphism rs3901901 was margin-
ally significant in Group 1. The association between asthma
phenotype and rs3901901 was further validated in Group 2
and Group 3. The results of this study indicated that poly-
morphisms of the ELF5 gene confer a risk for allergy but
with minor impact on pediatric asthma in the Taiwanese
population. The main limitation of this study was the low
number of SNPs in the investigated genomic region that
were selected for genotyping. The negative association
between the candidate genes regions (or haplotype) and
asthma may be due to the low density of SNP markers that
were genotyped.
The rs3901901SNP is located at position 18 kb from the
starting site of the ELF5 mRNA. Several SNPs in the 50 up-
stream region of ELF5 are in linkage disequilibrium
(r2  0.8) with rs3901901 (according to the Seattle SNPs
website http://pga.mbt.washington.edu/education.html;
Han-Chinese Beijing population). The observationGroup 2 Group 3
e Control Case Control
176 466 87
185 204 85
01 <0.0001
(1.39e2.68) 2.23 (1.59e3.14)
187 663 80
174 7 92
0001 <0.0001
(3.16, 6.85) 108.92 (48.81, 243.07)
common allergens.
Figure 1. Linkage disequilibrium plot in D0 demonstrating adjacent strength between single nucleotide polymorphism pairs at the
EHF and ELF5 genes. D0 values are multiplied by 100, for example, 76 in the square at the bottom means a D0 of 0.76. A square
without a number indicates a value of 100 that equals a D0 of 1.
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may contain polymorphic loci conferring asthma suscepti-
bility in our study population.
In Groups 1e3, the rs3901901 SNP only showed margin-
ally significant association with asthma. The minimal sam-
ple size for the detection of a significant association was
calculated using Power for Association With Errors (PAWE;
http://linkage.rockefeller.edu/pawe/).24,25 Under the
same ratio of condition and allele frequencies of rs3901901Table 2 c2 test for ELF5-EHF SNP genotyping
SNP ID Location Allele
1/2
ELF5
rs1535721 30 near gene A/G
rs4756153 Intron 4 A/G
rs942223 Intron 4 C/T
rs2231825 Intron 4 A/C
rs737254 Intron 3 G/T
rs35295760 Intron 2 A/G
rs836145 Intron 1 A/C
rs836141 50 near gene A/G
rs3901901 Intergenic A/G
EHF
rs717582 Intron 1 C/T
rs1453382 Intron 1 A/T
rs286902 Intron 2 C/T
rs286899 Intron 4 A/G
rs896856 Intron 6 G/T
rs2274438 Intron 7 A/G
rs2281908 30 near gene A/G
1: allele 1; 2: allele 2; 11: homozygous of allele 1; 12: heterozygous;
SNP Z single nucleotide polymorphism.in participants of the case and control groups from the total
number of participants, and assuming that the genotyping
data are without error, 1398 cases and 889 controls are
necessary to obtain enough statistical power (p Z 0.05,
power Z 0.8). The calculation suggested that our sample
size in Group 1e3 may not have been large enough to
detect a significant association between rs3901901 and
asthma. After pooling all study groups, the sample size
consisted of 1212 cases and 771 controls; however, theCase Control p
11/12/22 11/12/22
76/150/57 70/112/57 0.356
55/133/94 49/104/86 0.703
93/133/54 86/102/49 0.596
0/22/261 0/19/220 0.941
0/22/261 0/21/218 0.675
0/26/257 0/19/220 0.616
50/131/100 46/115/75 0.648
112/119/50 87/112/38 0.532
21/91/171 8/84/147 0.120
79/150/54 58/118/61 0.181
17/99/167 13/102/124 0.197
35/120/128 24/118/97 0.266
3/41/239 2/32/204 0.910
222/56/5 173/61/5 0.272
58/141/83 41/114/83 0.355
5/53/222 5/62/172 0.147
22: homozygous of allele 2.
Table 3 Genotyping frequencies, proportion, and odds ratio analyses of SNP rs3910901 in three independent groups
Genotype Group 1 Group 2 Group 3 Total
Case a Control b Case Control Case Control Case Control
CC 21 (7%) 8 (3%) 20 (8%) 15 (4%) 45 (7%) 5 (3%) 87 (7%) 28 (4%)
CG 91 (32%) 84 (35%) 86 (33%) 124 (34%) 227 (34%) 50 (29%) 404 (33%) 257 (33%)
GG 171 (60%) 147 (62%) 152 (59%) 222 (62%) 398 (59%) 117 (68%) 721 (60%) 486 (63%)
c2 4.2402 3.6543 5.9703 11.1944
p value 0.120 0.161 0.051 0.004
CC 21 8 20 15 45 5 87 28
CGþGG (ref) 262 231 238 346 625 167 1125 743
OR (95% CI) 2.31 (1.01, 5.33) 1.94 (0.97, 3.86) 2.40 (0.94, 6.15) 2.05 (1.33, 3.17)
p value 0.043 0.056 0.059 0.001
OR (95% CI)
adjust with sexc
2.51 (1.01, 5.92) 1.87 (0.93, 3.76) 2.49 (0.97, 6.42) 2.07 (1.33, 3.23)
p value 0.035 0.079 0.059 0.001
OR (95% CI)
adjust with allergyc
1.97 (0.81, 4.77) 1.52 (0.72, 3.18) 3.22 (0.85, 12.13) 1.76 (1.08, 2.87)
p value 0.135 0.271 0.084 0.024
OR (95% CI)
adjust with sex
and allergy c
2.21 (0.86, 5.58) 1.50 (0.72, 3.15) 3.18 (0.87, 11.67) 1.79 (1.09, 2.92)
p value 0.094 0.282 0.081 0.021
a Asthma patients.
b Nonasthma participants.
c SNP was coded as a categorical variable, 1 for CC, and 0 for others.
CI Z confidence interval; OR Z odds ratio; ref Z reference genotypes.
EHF-ELF5 and asthma 883power was still insufficient to detect an association be-
tween rs3901901 and asthma. Furthermore, the allele fre-
quencies of rs3901901 are different between the Caucasian
and Asian (Han Chinese) populations. The allele frequencies
of A (risk allele in this study) are 0.513 and 0.198 in the
Caucasian and Han Chinese Beijing populations, respec-
tively. The risk allele is less frequent in our study popula-
tion and thus a bigger sample size may be required to
identify an association between asthma and the EHF and
ELF5 genomic region in the Asian population. The risk ge-
notype AA, a minor genotype of rs3901901, was also was
consistently less frequent in the case group compared to
the controls (Table 3). The observation also suggested that
polymorphisms of the ELF5 gene may confer risk but with
minor impact on pediatric asthma in our study population.
In a mouse model, the level of Elf5 regulated the spec-
ification and differentiation of epithelial cells in the lung.26
Elf5 is dynamically expressed during lung development and
regulated by fibroblast growth factor through the phos-
phatidylinositol 3-kinase/Akt pathway.27 Elf5 regulates the
expression of key mediators of the PrlR/Jak2/Stat5
signaling pathway and plays an important role in mammary
gland development.28 ELF5 is expressed in some organs
such as the lung, stomach, kidney, prostate, bladder and
mammary gland and is suggested to play roles in mammary,
lung, prostate and/or kidney functions and possibly also in
tumorigenesis.29 In breast cancer, ELF5 provides a key
transcriptional determinant of molecular subtype bysuppression of estrogen sensitivity in luminal breast cancer
cells and promotion of basal characteristics in basal breast
cancer cells; an action that may be utilized to acquire
antiestrogen resistance.30 The loss-of-function mutations or
polymorphisms of ELF5 are unlikely to be associated with
chronic diseases such as asthma. It is suggested that the
regulatory polymorphisms of ELF5 play a role in the path-
ophysiological processes of asthma.
The results of this study suggest that ELF5 is a candidate
gene that confers genetic susceptibility for pediatric
asthma in the Taiwanese population. Furthermore, the re-
sults demonstrated a genetic basis in the pathogenesis of
asthma. Further investigations are required to understand
the functions and mechanisms of the associated SNPs in the
regulation of ELF5 expression.Conflicts of interest
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